Biocon trades lower on reporting 84% fall in Q2 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Biocon is currently trading at Rs. 307.50, down by 10.40 points or 3.27% from its previous closing of Rs. 317.90 on the BSE.
The scrip opened at Rs. 317.05 and has touched a high and low of Rs. 317.05 and Rs. 307.50 respectively. So far 43440 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 395.65 on 17-Sep-2024 and a 52 week low of Rs. 222.55 on 10-Nov-2023.
Last one week high and low of the scrip stood at Rs. 328.05 and Rs. 301.65 respectively. The current market cap of the company is Rs. 37320.65 crore.
The promoters holding in the company stood at 60.64%, while Institutions and Non-Institutions held 20.37% and 18.99% respectively.
Biocon has reported 90.78% fall in its net profit at Rs 3.20 crore for the quarter ended September 30, 2024 as compared to Rs 34.70 crore for the same quarter in the previous year. However, total income of the company increased by 1.80% at Rs 598.90 crore for Q2FY25 as compared to Rs 588.30 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 84.31% fall in net profit at Rs 27.10 crore for Q2FY25 as compared to Rs 172.70 crore for the same quarter in the previous year. However, total income of the company increased by 0.07% at Rs 3622.90 crore for Q2FY25 as compared to Rs 3620.20 crore for the corresponding quarter previous year.
